Skip to main content
SpringerLink
Log in

The major intervention studies

  • Chapter
Lipids in Human Nutrition

  • 84 Accesses

Abstract

Cardiovascular disease is the main cause of mortality in countries with a high standard of living such as Canada, the United States of America, Great Britain and Scandinavia. Atherosclerosis appears to be the principal underlying condition responsible for the clinical manifestations of cardiovascular diseases and other circulatory disorders, heart attacks and sudden death. Atherosclerosis is characterized by the presence in the arterial walls of lipid-rich deposits. These deposits can cause partial or even complete occlusion of certain arteries. It is still impossible to prevent the formation of atherosclerotic deposits or to induce their regression. Despite 200 years of observation and research, the cause of atherosclerosis remains largely unknown and it is still impossible, for all practical purposes, to modify to any great degree its course or avoid its consequences1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Borhani NO: Primary prevention of coronary heart disease: a critique. Am J Cardiol, 40: 251–259, 1977

    Article  CAS  PubMed  Google Scholar 

  2. Keys A: Coronary heart disease in seven countries. American Heart Association, Monograph 29. Circulation, 41:suppl I, 1970

    Google Scholar 

  3. Masironi R: Dietary factors and coronary heart disease. Bull WHO, 42: 103–114, 1970.

    CAS  PubMed  Google Scholar 

  4. Armstrong BK, Mann JI, Adelstein AM, Eskin F: Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices. J Chron Dis, 28: 455–469, 1975

    Article  CAS  PubMed  Google Scholar 

  5. Kannel WB: Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol, 37: 269–282, 1976

    Article  CAS  PubMed  Google Scholar 

  6. Stamler J: Population studies. In Levy RI, Rifkind BM, Dennis BH, Ernst ND (eds) Nutrition, Lipids, and Coronary Heart Disease. A Global View, p 57. New York, Raven Press, 1979

    Google Scholar 

  7. Tyroler HA, Heyden S, Bartel A, Cassel J, Cornoni JC, Hames CG, Kleinbaum D: Blood pressure and cholesterol as coronary risk factors. Arch Intern Med, 128: 907–914, 1971

    Article  CAS  PubMed  Google Scholar 

  8. Miller NE, Thelle DS, Førde OH, Mjøs OD: The Troms¢ heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet, 1: 965–970, 1977

    Article  CAS  PubMed  Google Scholar 

  9. Robertson TL, Kato H, Gordon T, Kagan A, Rhoads GG, Land CE, Worth RM, Belsky JL, Dock DS, Miyanishi M, Kawamoto S: Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Coronary heart disease risk factors in Japan and Hawaii. Am J Cardiol, 39: 244–249, 1977

    Article  CAS  PubMed  Google Scholar 

  10. McGee D, Gordon T: The Framingham Study—an epidemiological investigation of cardiovascular disease. Section 31. The results of the Framingham Study applied to four other U.S.-based epidemiologic studies of cardiovascular disease, U.S. Department of Health, Education, and Welfare. DHEW Publication No (NM) 76–1083, Washington, DC, 1976

    Google Scholar 

  11. Tibblin G, Wilhelmsen L, Werkö L: Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol, 35: 514–522, 1975

    Article  CAS  PubMed  Google Scholar 

  12. Sherwin R: Controlled trials of the diet-heart hypothesis: some comments on the experimental unit. Am J Epidemiol, 108: 92–99, 1978

    CAS  PubMed  Google Scholar 

  13. Wright IS: Correct levels of serum cholesterol. Average vs normal vs optimal. JAMA, 236: 261–262, 1976

    Article  CAS  PubMed  Google Scholar 

  14. Hulley SB, Rosenman RH, Bawol RD, Brand RJ: Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med, 302: 1383–1389, 1980

    Article  CAS  PubMed  Google Scholar 

  15. Turpeinen O. Karvonen MJ, Pekkarinen M, Miettinen M, Elosuo R, Paavilainen E: Dietary prevention of coronary heart disease: the finnish mental hospital study. Int J Epidemiol, 8: 99–118, 1979

    Article  CAS  PubMed  Google Scholar 

  16. Dayton S, Pearce ML, Hashimoto S, Dixon WJ, Tomiyasu U: A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation, 40 (suppl 2): 1–63, 1969

    Google Scholar 

  17. Stamler J: Acute myocardial infarction—progress in primary prevention. Br Heart J, 33 (suppl): 145–164, 1971

    Article  PubMed Central  PubMed  Google Scholar 

  18. Christakis G, Rinzler SH, Archer M, Krauss A: Effect of the anti-coronary club program on coronary heart disease risk-factor status. JAMA, 198: 597–604, 1966

    Article  CAS  PubMed  Google Scholar 

  19. Miettinen M, Turpeinen O, Karvonen MJ, Elosuo R, Paavilainen E: Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet, 2: 835–838, 1972

    Article  CAS  PubMed  Google Scholar 

  20. Oliver MF, Heady JA, Morris JN, Cooper J: A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. Br Heart J, 40: 1069–1103, 1978

    Article  Google Scholar 

  21. Halperin M, Cornfield J, Mitchell SC: Effect of diet on coronary-heart-disease mortality. Lancet, 2: 438–439, 1973

    Article  CAS  PubMed  Google Scholar 

  22. Ahrens EH Jr: The management of hyperlipidemias: whether, rather than how. Ann Intern Med, 85: 87–93, 1976

    Article  PubMed  Google Scholar 

  23. Rose GA, Thomson, WB, Williams RT: Corn oil in treatment of ischaemic heart disease. Br Med J, 1: 1531–1533, 1965

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Morris JN, Ball KP: Controlled trial of soya-bean oil in myocardial infarction. Report of a research committee to the medical research council. Lancet, 2: 693–699, 1968

    Google Scholar 

  25. Leren P: The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Med Scand, 466 (suppl): 5–92, 1966

    Google Scholar 

  26. Bierenbaum ML, Fleischman Al, Raichelson, RI, Hayton T, Watson PB: Ten-year experience of modified-fat diets on younger men with coronary heart-disease. Lancet, 1: 1404–1407, 1973

    Article  CAS  PubMed  Google Scholar 

  27. Woodhill JM, Palmer AJ, Leelarthalpin B, McGilchrist C, Blacket RB: Low fat, low cholesterol diet in secondary prevention of coronary heart disease. In Kritchevsky D, Paoletti R, Holmes WL (eds) Drugs, Lipids and Atherosclerosis, pp 317–330. New York, Plenum Press, 1977

    Google Scholar 

  28. Coronary Drug Project Research Group: The Coronary Drug Project. Initial findings leading to modifications of its research protocol. JAMA, 214: 1303–1313, 1970

    Article  Google Scholar 

  29. Coronary Drug Project Research Group: The Coronary Drug Project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. JAMA, 220: 996–1008, 1972

    Article  Google Scholar 

  30. Coronary Drug Project Research Group: The Coronary Drug Project. Findings leading to discontinuation of the 2.5mg/day estrogen JAMA, 226: 652–657, 1973

    Article  Google Scholar 

  31. Coronary Drug Project Research Group: Clofibrate and niacin in coronary heart disease. JAMA, 231: 360–381, 1975

    Article  Google Scholar 

  32. Oliver MF: Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians. Br Med J, 4: 775–784, 1971

    Article  Google Scholar 

  33. Anonyme: Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region. Br Med J, 4: 767–775, 1971

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Université Laval, Québec, Canada

    Germain J. Brisson Ph.D. (Professor of Nutrition)

Authors
  1. Germain J. Brisson Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer Science+Business Media New York

About this chapter

Cite this chapter

Brisson, G.J. (1981). The major intervention studies. In: Lipids in Human Nutrition. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-7212-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-94-015-7212-5_7

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-015-7214-9

  • Online ISBN: 978-94-015-7212-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation